Literature DB >> 25545877

Association of haematocrit and red blood cell transfusion with outcomes in infants with shunt-dependent pulmonary blood flow and univentricular physiology.

Rahul Dasgupta1, Andrew Parsons2, Sarenthia Mcclelland2, Elizabeth Morgan2, Michael J Robertson2, Tommy R Noel3, Michael L Schmitz1, Mallikarjuna Rettiganti4, Punkaj Gupta3.   

Abstract

BACKGROUND: The aim of this study was to investigate the association between red blood cell (RBC) transfusion and haematocrit values with outcomes in infants with univentricular physiology undergoing surgery for a modified Blalock-Taussig shunt.
MATERIAL AND METHODS: This study included infants ≤ 2 months of age who underwent modified Blalock-Taussig shunt surgery at the Arkansas Children's Hospital (2006-2012). Infants undergoing a Norwood operation or Damus-Kaye-Stansel operation with modified Blalock-Taussig shunt were excluded. Demographics, pre-operative, operative, daily laboratory data, and post-operative variables were collected. We studied the association between haematocrit and blood transfusion with a composite clinical outcome. Multivariable logistic regression models were fitted to study the probability of study outcomes as a function of haematocrit values and RBC transfusions after operation.
RESULTS: Seventy-three patients qualified for inclusion. All study patients received blood transfusion within the first 48 hours after heart surgery. The median haematocrit was 44.3 (interquartile range [IQR] 42.5-46.2), and the median volume of RBC transfused was 28 mL/kg (IQR, 10-125) in the first 14 days after surgery. The overall in-hospital mortality rate was 13.6% (10 patients). A multivariable analysis adjusted for risk factors, including weight, prematurity, cardiopulmonary bypass and postoperative need for nitric oxide and dialysis, revealed no association between haematocrit values and RBC transfusion with the composite clinical outcome. DISCUSSION: We did not find an association between higher haematocrit values and increasing RBC transfusions with improved outcomes in infants with shunt-dependent pulmonary blood flow and univentricular physiology. The power of our study was small, which prevents any strong statement on this lack of association. Future multi-centre, randomised controlled trials are needed to investigate this topic in further detail.

Entities:  

Mesh:

Year:  2014        PMID: 25545877      PMCID: PMC4614293          DOI: 10.2450/2014.0128-14

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  21 in total

Review 1.  Guidelines for assessing appropriateness of pediatric transfusion.

Authors:  Susan D Roseff; Naomi L C Luban; Catherine S Manno
Journal:  Transfusion       Date:  2002-11       Impact factor: 3.157

2.  Determinants of red blood cell transfusions in a pediatric critical care unit: a prospective, descriptive epidemiological study.

Authors:  Ruth Armano; France Gauvin; Thierry Ducruet; Jacques Lacroix
Journal:  Crit Care Med       Date:  2005-11       Impact factor: 7.598

3.  Pediatric red blood cell transfusions increase resource use.

Authors:  Allyson M Goodman; Murray M Pollack; Kantilal M Patel; Naomi L C Luban
Journal:  J Pediatr       Date:  2003-02       Impact factor: 4.406

Review 4.  Blood transfusion support in pediatric cardiovascular surgery.

Authors:  J L Kwiatkowski; C S Manno
Journal:  Transfus Sci       Date:  1999-08

5.  A Canadian survey of transfusion practices in critically ill patients. Transfusion Requirements in Critical Care Investigators and the Canadian Critical Care Trials Group.

Authors:  P C Hébert; G Wells; C Martin; M Tweeddale; J Marshall; M Blajchman; G Pagliarello; I Schweitzer; L Calder
Journal:  Crit Care Med       Date:  1998-03       Impact factor: 7.598

6.  Red blood cell transfusion in critically ill children is independently associated with increased mortality.

Authors:  Martin C J Kneyber; Mohammed I Hersi; Jos W R Twisk; Dick G Markhorst; Frans B Plötz
Journal:  Intensive Care Med       Date:  2007-06-16       Impact factor: 17.440

7.  Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest.

Authors:  G Wernovsky; D Wypij; R A Jonas; J E Mayer; F L Hanley; P R Hickey; A Z Walsh; A C Chang; A R Castañeda; J W Newburger; D L Wessel
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

8.  Evolution of adverse changes in stored RBCs.

Authors:  Elliott Bennett-Guerrero; Tim H Veldman; Allan Doctor; Marilyn J Telen; Thomas L Ortel; T Scott Reid; Melissa A Mulherin; Hongmei Zhu; Raymond D Buck; Robert M Califf; Timothy J McMahon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-11       Impact factor: 11.205

9.  S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood.

Authors:  James D Reynolds; Gregory S Ahearn; Michael Angelo; Jian Zhang; Fred Cobb; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-11       Impact factor: 11.205

10.  Transfusion strategies for patients in pediatric intensive care units.

Authors:  Jacques Lacroix; Paul C Hébert; James S Hutchison; Heather A Hume; Marisa Tucci; Thierry Ducruet; France Gauvin; Jean-Paul Collet; Baruch J Toledano; Pierre Robillard; Ari Joffe; Dominique Biarent; Kathleen Meert; Mark J Peters
Journal:  N Engl J Med       Date:  2007-04-19       Impact factor: 91.245

View more
  2 in total

1.  The effects of postoperative hematocrit on shunt occlusion for neonates undergoing single ventricle palliation.

Authors:  Brett R Anderson; Victoria L Blancha; Jennifer M Duchon; Paul J Chai; David Kalfa; Emile A Bacha; Ganga Krishnamurthy; Veniamin Ratner
Journal:  J Thorac Cardiovasc Surg       Date:  2016-11-14       Impact factor: 5.209

2.  Red blood cell transfusion threshold after pediatric cardiac surgery: A systematic review and meta-analysis.

Authors:  Xicheng Deng; Yefeng Wang; Peng Huang; Jinwen Luo; Yunbin Xiao; Jun Qiu; Guangxian Yang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.